Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000229302 | SCV000283036 | pathogenic | Ataxia-telangiectasia syndrome | 2016-01-14 | criteria provided, single submitter | clinical testing | This sequence change deletes 1 nucleotide from exon 49 of the ATM mRNA (c.7091delC), causing a frameshift at codon 2364. This creates a premature translational stop signal (p.Ala2364Glufs*2) and is expected to result in an absent or disrupted protein product. While this particular variant has not been reported in the literature, truncating variants in ATM are known to be pathogenic (PMID: 25614872, 23807571). For these reasons, this variant has been classified as Pathogenic. |